• Contact Us
  • Japanese
  • Search
  • Menu

JSR Corporation

  • Corporate
    Profile
    Corporate Profile TOP
    • JSR CEO's Message
    • The JSR Group's Essential Elements
    • Corporate Governance
    • About JSR
    • Management and Corporate Organization
    • Offices and Sites
    • Main Group Enterprises
    • History
  • Business
    Introduction
    Business Introduction TOP
    • Electronic Materials Business
    • Display Solution Business
    • Optical Solution Business
    • Plastics Business
    • Life Sciences Business
    • Product List
  • Research and
    Development
    Research and Development TOP
    • R&D Policy
    • R&D Organization
    • Intellectual Property Activities
    • Published Papers
    • Awards
    • Others
  • Financial
    Information
    Financial Information TOP
    • Who is JSR?
    • Financial and Performance Highlights
    • Library
    • Corporate Bond and Rating Information
    • Financial News
  • Sustainability
    Sustainability TOP
    • Message from Our Chief Sustainability Officer
    • JSR Group’s Materiality
    • ESG Initiatives
    • ESG Data
    • Evaluation by Society
    • Social Contributions
  • News
  1. HOME
  2. News
  3. 2023
  4. KBI Biopharma and Selexis SA Appoint J.D. Mowery as CEO

KBI Biopharma and Selexis SA Appoint J.D. Mowery as CEO

04/18/2023
Corporate

KBI Biopharma, Inc. and Selexis SA, both JSR Life Sciences companies, announced the appointment of J.D. Mowery as Chief Executive Officer (CEO).

For details, please see the announcement from JSR Life Sciences LLC on URL.
https://news.jsrlifesciences.com/224979-kbi-biopharma-and-selexis-sa-appoint-j-d-mowery-as-ceo

  • Back to INDEX
  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • Contact Us
  • Privacy Policy
  • Use of the Site
  • Site Map
Copyright © JSR Corporation. ALL rights reserved.
Page top